Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein, covering 2024-02-28 to 2024-02-28. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein [Phase 3]